Dr. Magoola wins prestigious Molecular Biologist Award for his mRNA cutting edge vaccines research
Dr. Matthias Magoola is leading the charge on using mRNA technology to make affordable human medicines and vaccines KAMPALA - ...
Dr. Matthias Magoola is leading the charge on using mRNA technology to make affordable human medicines and vaccines KAMPALA - ...
Rwanda President Paul Kagame Rwanda's Ministry of Health has confirmed cases of Marburg virus disease (MVD), a severe hemorrhagic fever, ...
Dr. Matthias Magoola has commended President Museveni for his unwavering support to scientists KAMPALA – Dr. Matthias Magoola, the founder and Chief ...
Dei Group of Companies Chief Executive and Founder Dr. Matthias Magoola was recognized at the coronation ceremony as the leading ...
Dei Biopharma Vaccines Facility:Giving Africa a new leap Under the facility that stands on 150 acres of land, Dei Biopharma Ltd will make ...
KAMPALA — President Yoweri Museveni will tomorrow, November 28, commission a diagnostic test kits manufacturing plant, the first of its ...
Low cost drugs. The multi-million dollar biological drugs and vaccines manufacturing facility in Mattuga, Wakiso, Uganda being developed by Dei ...
Uganda government has agreed to inject UGX. 18 trillion into Dei Biopharm Vaccines Plant in Matugga (PHOTO/Courtesy). MATUGGA —Uganda risks ...
© 2024 Ugstandard - Latest News by Digital/New Media company.